Mechanisms of SFG Rickettsia-Host Interactions
SFG 立克次体与宿主相互作用的机制
基本信息
- 批准号:10468216
- 负责人:
- 金额:$ 55.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-12 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Ankyrin RepeatBacterial InfectionsBacterial ProteinsBiochemicalBiologicalBiological AssayBiologyCell Adhesion MoleculesCell physiologyCell-Cell AdhesionCellsCellular biologyCessation of lifeComplementComplexCytosolDevelopmentDiagnosticEctopic ExpressionExanthemaFutureGenesGeneticGenetic VariationGenetic studyGoalsHumanImpairmentInfectionIntegration Host FactorsIntercellular JunctionsInvadedLabelLaboratoriesLeadLifeLife Cycle StagesLocationMediatingMetabolicMicroscopyModelingModernizationMolecularMutagenesisPathogenesisPathogenicityPathway interactionsPhasePlasmidsPropertyProteinsProteomicsResearchRickettsiaRickettsia InfectionsRickettsia parkeriSiteStructureSystemTechniquesTestingTherapeutic InterventionTick-Borne DiseasesTick-Borne InfectionsTimeType IV Secretion System PathwayUnited States National Institutes of HealthVascular DiseasesVinculinWidespread DiseaseWorkbasecombatdesignforward geneticsgenetic approachgenetic manipulationimprovedinsightinterestmembermutantpathogenpathogenic bacteriapreventspotted fevertargeted treatmenttherapeutic targettick-bornetool
项目摘要
PROJECT SUMMARY/ABSTRACT
A subset of emerging, but poorly characterized tickborne diseases in the U.S. are caused by Spotted Fever
Group (SFG) Rickettsia. These obligate intracellular bacterial pathogens cause mild-to-life-threatening vascular
diseases in humans and have a limited set of diagnostics and therapeutic interventions. To promote widespread
disease, SFG Rickettsia species have evolved dynamic strategies to invade host cells, escape into the cytosol,
and spread from cell to cell. We hypothesize that SFG Rickettsia coordinate their complex life cycle by delivering
an arsenal of secreted bacterial proteins (i.e., effectors) that reprogram host cell processes. Unfortunately, the
identity and host targets of these secreted effectors have remained largely unknown. Furthermore, direct analysis
of the secretion systems and putative effectors have been hampered due to challenges in growing and
genetically manipulating these pathogens in the lab. To overcome this barrier, we recently adapted forward
genetics and plasmid-based complementation to the model SFG member Rickettsia parkeri, allowing for
powerful functional-genetic studies of SFG Rickettsia pathogenesis. Using these tools, we discovered that the
secreted effector Sca4 promotes a late stage of cell-to-cell spread by manipulating host cell-cell adhesion.
Additionally, transposon mutagenesis of a secreted effector of unknown function (RARP-1) and a component of
the anomalous Rickettsia Type 4 secretion system (VirB6e) impairs distinct stages of R. parkeri infection. This
proposal will leverage these key advances to examine how a secretion system and secreted effectors promote
different steps of the R. parkeri infectious life cycle. Here, we combine our functional-genetic strategies and
expertise in host cell biology, with modern biochemical techniques to reveal critical, mechanistic insights into
SFG Rickettsia pathogenesis. In Aim 1, we will examine the function and secretome of the T4SS component
VirB6e. In Aim 2, we will determine how the secreted effector RARP-1 promotes R. parkeri infection. In Aim 3,
we will elucidate how Sca4 specifically targets host cell-cell adhesion complexes during R. parkeri cell-to-cell
spread. Collectively, the proposed research will dramatically improve our fundamental understanding of
Rickettsia biology and Rickettsia-host interactions and reveal therapeutic targets to prevent or treat tickborne
diseases.
项目总结/摘要
在美国,一种新出现的、但特征不明显的蜱传疾病是由斑疹热引起的。
组(SFG)立克次体。这些专性细胞内细菌病原体引起轻度至危及生命的血管
人类疾病,并有一套有限的诊断和治疗措施。为促进普遍
疾病时,SFG立克次体物种已经进化出动态策略来侵入宿主细胞,逃逸到胞质溶胶中,
并在细胞间传播我们假设SFG立克次体通过传递
分泌的细菌蛋白质的武库(即,效应子),其重编程宿主细胞过程。可惜
这些分泌的效应物的身份和宿主靶点在很大程度上仍然未知。此外,直接分析
分泌系统和假定的效应器的功能受到阻碍,
在实验室里对这些病原体进行基因操作。为了克服这一障碍,我们最近进行了调整,
遗传学和质粒为基础的互补模式SFG成员立克次体parkeri,允许
SFG立克次体致病机制的功能遗传学研究。使用这些工具,我们发现,
分泌的效应因子Sca 4通过操纵宿主细胞-细胞粘附促进细胞-细胞扩散的晚期阶段。
此外,功能未知的分泌效应子(RARP-1)和
立克次体4型异常分泌系统(VirB 6 e)损害了R. parkeri感染。这
一项提案将利用这些关键进展来研究分泌系统和分泌的效应物如何促进
R. Parkeri感染性生命周期在这里,我们联合收割机结合我们的功能遗传策略,
在宿主细胞生物学的专业知识,与现代生物化学技术,揭示关键,机械的见解,
SFG立克次体发病机制。在目标1中,我们将研究T4 SS组分的功能和分泌组
VirB6e。在目标2中,我们将确定分泌的效应子RARP-1如何促进R。parkeri感染。在目标3中,
我们将阐明Sca 4在R. parkeri细胞对细胞
传播.总的来说,拟议的研究将大大提高我们对
立克次体生物学和立克次体-宿主相互作用,并揭示预防或治疗蜱传的治疗靶点
疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
REBECCA L LAMASON其他文献
REBECCA L LAMASON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('REBECCA L LAMASON', 18)}}的其他基金
Microbial Control of Host Intercellular Communication
宿主细胞间通讯的微生物控制
- 批准号:
10363966 - 财政年份:2022
- 资助金额:
$ 55.82万 - 项目类别:
Microbial Control of Host Intercellular Communication
宿主细胞间通讯的微生物控制
- 批准号:
10661500 - 财政年份:2022
- 资助金额:
$ 55.82万 - 项目类别:
Mechanisms of SFG Rickettsia-Host Interactions
SFG 立克次体与宿主相互作用的机制
- 批准号:
10293664 - 财政年份:2021
- 资助金额:
$ 55.82万 - 项目类别:
Mechanisms of SFG Rickettsia-Host Interactions
SFG 立克次体与宿主相互作用的机制
- 批准号:
10651764 - 财政年份:2021
- 资助金额:
$ 55.82万 - 项目类别:
Elucidating how intracellular bacterial pathogens hijack host intercellular communication to promote spread
阐明细胞内细菌病原体如何劫持宿主细胞间通讯以促进传播
- 批准号:
9132279 - 财政年份:2015
- 资助金额:
$ 55.82万 - 项目类别:
Elucidating how intracellular bacterial pathogens hijack host intercellular communication to promote spread
阐明细胞内细菌病原体如何劫持宿主细胞间通讯以促进传播
- 批准号:
9529899 - 财政年份:2015
- 资助金额:
$ 55.82万 - 项目类别:
Regulation of CARD11 by a kinesin-like protein, GAKIN
驱动蛋白样蛋白 GAKIN 对 CARD11 的调节
- 批准号:
7406429 - 财政年份:2007
- 资助金额:
$ 55.82万 - 项目类别:
Regulation of CARD11 by a kinesin-like protein, GAKIN
驱动蛋白样蛋白 GAKIN 对 CARD11 的调节
- 批准号:
7505435 - 财政年份:2007
- 资助金额:
$ 55.82万 - 项目类别:
Regulation of CARD11 by a kinesin-like protein, GAKIN
驱动蛋白样蛋白 GAKIN 对 CARD11 的调节
- 批准号:
7671431 - 财政年份:2007
- 资助金额:
$ 55.82万 - 项目类别:
相似海外基金
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
- 批准号:
10649771 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
- 批准号:
10574286 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
- 批准号:
10644889 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
- 批准号:
MR/X031993/1 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
- 批准号:
EP/X014479/1 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
- 批准号:
10588846 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
- 批准号:
10073241 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别:
Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 55.82万 - 项目类别: